PARI

April 10, 2015November 5, 2015

Vantobra By PARI Pharma Received Marketing Authorization In Europe for Cystic Fibrosis

Cystic Fibrosis, News

Vantobra® by PARI Pharma is a novel, highly concentrated tobramycin nebulizer solution for inhalation delivered by a Tolero® nebuliser that received a Marketing Authorization granted by the European Commission in March. Vantobra offers ... Read more

March 5, 2015November 9, 2015

Sunovion Launches Phase 3 Clinical Trial For First Nebulizer-Delivered LAMA for COPD

COPD, News

Sunovion Pharmaceuticals Inc. recently announced the beginning of enrollment for its Phase 3 clinical trial plan for SUN-101 (glycopyrrolate) solution for inhalation to be delivered through the investigational eFlow®nebulizer system (SUN-101/eFlow®) from PARI Pharma GmbH. ... Read more

February 17, 2015November 5, 2015

PARI PROVIDE Program Gives Kitabis Pak CF Users Access to FDA-Approved Compressors for Bacterial Infection Treatment

Cystic Fibrosis, News

PARI, a company working on the development and commercialization of effective aerosol delivery systems (drug and device) for patients suffering from respiratory disorders like cystic fibrosis, chronic lung disease and asthma, has announced ... Read more